|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
48,973,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Arcellx is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Co.'s D-Domain powered autologous and allogeneic Chimeric Antigen Receptor T cells (CAR-Ts), including classical single infusion CAR-Ts product candidate, CART-ddBCMA, is for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM), defined as patients with either minimal response or disease progression within 60 days of last treatment. Co. is also developing its ARC-SparX programs, ACLX-001 in r/r MM and ACLX-002 and ACLX-003 in r/r acute myeloid leukemia and myelodysplastic syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
312,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$5,000,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
665,735 |
1,335,183 |
3,353,154 |
3,456,214 |
| Total Sell Value |
$46,017,101 |
$79,309,104 |
$168,911,661 |
$172,412,706 |
| Total People Sold |
5 |
5 |
6 |
10 |
| Total Sell Transactions |
14 |
19 |
30 |
45 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Heery Christopher |
Chief Medical Officer |
• – – |
2023-08-04 |
4 |
AS |
$35.38 |
$106,133 |
D/D |
(3,000) |
7,795 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-08-04 |
4 |
OE |
$15.00 |
$45,000 |
D/D |
3,000 |
10,795 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-07-03 |
4 |
AS |
$31.75 |
$95,246 |
D/D |
(3,000) |
7,795 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-07-03 |
4 |
OE |
$15.00 |
$45,000 |
D/D |
3,000 |
10,795 |
|
- |
|
| Behbahani Ali |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
28 |
85 |
|
- |
|
| Behbahani Ali |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
113 |
339 |
|
- |
|
| Carroll Jill |
Director |
– • – |
2023-06-01 |
4 |
S |
$44.35 |
$1,133,317 |
I/I |
(25,556) |
2,487,674 |
|
- |
|
| Elghandour Rami |
See Remarks |
• • – |
2023-05-31 |
4 |
S |
$44.27 |
$115,099 |
D/D |
(2,600) |
36,169 |
|
- |
|
| Carroll Jill |
Director |
– • – |
2023-05-31 |
4 |
S |
$41.50 |
$13,079,306 |
I/I |
(315,164) |
2,513,230 |
|
- |
|
| Gilson Michelle |
Chief Financial Officer |
• – – |
2023-05-25 |
4 |
S |
$42.77 |
$256,616 |
D/D |
(6,000) |
9,485 |
|
- |
|
| Gilson Michelle |
Chief Financial Officer |
• – – |
2023-05-24 |
4 |
S |
$41.64 |
$369,534 |
D/D |
(8,704) |
15,485 |
|
- |
|
| Gilson Michelle |
Chief Financial Officer |
• – – |
2023-05-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,428 |
24,189 |
|
- |
|
| Carroll Jill |
Director |
– • – |
2023-05-11 |
4 |
S |
$45.00 |
$28,736,223 |
I/I |
(638,417) |
2,828,394 |
|
- |
|
| Sr One Co-Invest Ii Manager, Llc |
10% Owner |
– – • |
2023-05-11 |
4 |
S |
$45.00 |
$45,589,317 |
I/I |
(1,012,833) |
1,658,780 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-05-10 |
4 |
AS |
$45.18 |
$99,266 |
D/D |
(2,197) |
7,795 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-05-09 |
4 |
AS |
$45.00 |
$22,500 |
D/D |
(500) |
9,992 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-05-05 |
4 |
AS |
$45.00 |
$54,002 |
D/D |
(1,200) |
10,492 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-05-03 |
4 |
AS |
$42.72 |
$130,329 |
D/D |
(3,000) |
11,692 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-05-03 |
4 |
OE |
$15.00 |
$45,000 |
D/D |
3,000 |
14,692 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-04-24 |
4 |
AS |
$40.00 |
$800,068 |
D/D |
(20,000) |
11,692 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-04-24 |
4 |
OE |
$6.28 |
$212,800 |
D/D |
20,000 |
31,692 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-04-19 |
4 |
AS |
$35.01 |
$547,661 |
D/D |
(15,642) |
11,692 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-04-19 |
4 |
OE |
$6.28 |
$162,503 |
D/D |
12,345 |
27,334 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-04-18 |
4 |
AS |
$35.00 |
$210,000 |
D/D |
(6,000) |
14,989 |
|
- |
|
| Heery Christopher |
Chief Medical Officer |
• – – |
2023-04-18 |
4 |
OE |
$6.28 |
$54,840 |
D/D |
5,400 |
20,989 |
|
- |
|
84 Records found
|
|
Page 2 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
